Michael A. Metzger - 25 Jul 2022 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael A. Metzger
Issuer symbol
SNDX
Transactions as of
25 Jul 2022
Net transactions value
-$463,772
Form type
4
Filing time
27 Jul 2022, 18:42:22 UTC
Previous filing
11 Jul 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $126,094 +19,764 +112% $6.38 37,423 25 Jul 2022 Direct
transaction SNDX Common Stock Sale $416,139 -19,764 -53% $21.06 17,659 25 Jul 2022 Direct F1, F2
transaction SNDX Common Stock Options Exercise $75,526 +11,838 +67% $6.38 29,497 25 Jul 2022 Direct
transaction SNDX Common Stock Sale $249,254 -11,838 -40% $21.06 17,659 25 Jul 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -19,764 -100% $0.000000* 0 25 Jul 2022 Common Stock 19,764 $6.38 Direct F3
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -11,838 -100% $0.000000* 0 25 Jul 2022 Common Stock 11,838 $6.38 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 670,466 options to purchase shares of common stock that are vested and immediately exercisable and a total of 539,063 options to purchase shares of common stock that have not yet vested.
F2 The sale prices ranged from $21.00 to $21.16.
F3 This option vests in 48 successive equal monthly installments measured from 02/06/2019.
F4 This option vests periodically upon the Issuer achieving certain milestones.